AnandRathi

Glenmark Pharmaceuticals Ltd Fundamental Analysis

Last Updated Date: 27 Aug 2026
2,456.00
+16.00 (+0.66%)

Glenmark Pharmaceuticals Ltd (Glenmark Pharma.) fundamental analysis breaks down the key financial metrics of the mid-cap Pharmaceuticals company, which carries a market capitalisation of ₹69,314 crore.

Glenmark Pharmaceuticals Ltd Overview

Market cap₹69,314 Crs
Volume17,019
Prev. Close₹2,440.00
Year range₹1,794.00 - ₹2,471.05
Total Value₹4,17,98,664.00
ISININE935A01035

Glenmark Pharmaceuticals Ltd Fundamental Analysis

ROCE(TTM)6.29%
P/E Ratio (TTM)338.76
P/B Ratio2.87
Debt to Equity0.00
ROE6.63%
EPS (TTM)51.73
Dividend Yield0.20%
Book Value855.71
Profit Margin18.03%
Operating Margin8.51%

Glenmark Pharmaceuticals Ltd Historical Performance

1 Month Return11.92%
6 Month Return14.89%
3 Year Return220.21%
3 Month Return3.08%
1 Year Return25.79%
5 Year Return365.11%

Glenmark Pharmaceuticals Ltd Share Price History

High:0.00
Low:0.00
No History Available

Disclaimer

The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...

Frequently Asked Questions

Download TradeMobi App

  • Real-Time Market Data
  • Advanced Trading Tools
  • Expert-Backed Research